The New College Experience
As schools of all levels struggle to find a new way to educate students, universities, in particular, have had a difficult time navigating classes and campus life. On this week's show, we talk to a st...
26 Syys 202018min
Can We Trust A Vaccine That Gets Approved?
On this week's episode of PODCAST-19, we discuss whether the FDA vaccine approval process can withstand political interference and how the agency can reassure the public that everything is working as ...
19 Syys 202020min
Why A Vaccine Trial Would Press Pause
We discuss the news that AstraZeneca's COVID-19 vaccine trial has been paused because of a severe side effect for one participant, and how temporarily halting a trial can sometimes mean the process is...
12 Syys 202018min
The U.S. Wants Out Of A Global Effort To Stop A Global Pandemic
The U.S. doesn't want to participate in a global effort to find and distribute a vaccine for COVID-19. Anna talks with FiveThirtyEight senior science writer Maggie Koerth about what that decision migh...
4 Syys 202011min
What's It Going To Take For Us To Become Immune?
On this week's episode, we explore what it means that people can get reinfected with COVID-19, and how we can still develop immunity to the disease. We also explore why the approach to masks in the Ne...
28 Elo 202031min
Russia Approved A COVID Vaccine. Will It Be Available In America?
Russia is the first country in the world to approve a vaccine for COVID-19. To do so, they've reportedly sped through multiple steps in the testing process. Judy Twigg, a political scientist from Virg...
14 Elo 202031min
PODCAST-19 Has The Week Off!
We were no match for extreme weather this week, but we'll be back next week!
7 Elo 202024s
Lab-Grown Antibodies Might Protect Essential Workers
This week on Podcast-19, we talk about lab-grown antibodies, called monoclonal antibodies, that could temporarily protect people from COVID-19. How soon might they be available for the public? We also...
31 Heinä 202023min
